TY - JOUR
T1 - Role of microRNA-27a in down-regulation of angiogenic factor AGGF1 under hypoxia associated with high-grade bladder urothelial carcinoma
AU - Xu, Yan
AU - Zhou, Ming
AU - Wang, Jingjing
AU - Zhao, Yuanyuan
AU - Li, Sisi
AU - Zhou, Bisheng
AU - Su, Zhenhong
AU - Xu, Chengqi
AU - Xia, Yue
AU - Qian, Huijun
AU - Tu, Xin
AU - Xiao, Wei
AU - Chen, Xiaoping
AU - Chen, Qiuyun
AU - Wang, Qing K.
N1 - Funding Information:
We thank Lei Li, Nan Wang, Yufeng Yao, Qiulun Lv and other members of Center for Human Genome Research for discussion and advice. This work was supported by a National Basic Research (973) Program Grant ( 2013CB0531101 ), the Hubei Province's Outstanding Medical Academic Leader Program, the Specialized Research Fund for the Doctoral Program of Higher Education from the Ministry of Education , the “Innovative Development of New Drugs” Key Scientific Project ( 2011ZX09307-001-09 ), a Grant from the State Key Laboratory of Freshwater Ecology and Biotechnology ( 2011FB16 ), the Fundamental Research Funds for the Central Universities ( 2010MS015 ), and the Key Academic Program Leader Award of Wuhan City ( 200951830560 ).
PY - 2014/5
Y1 - 2014/5
N2 - Hypoxia stimulates angiogenesis under a variety of pathological conditions, including malignant tumors by inducing expression of angiogenic factors such as VEGFA. Surprisingly, here we report significant association between down-regulation of a new angiogenic factor AGGF1 and high-grade urothelial carcinoma. The proportion of strong AGGF1 expression cases was significantly lower in the high-grade urothelial carcinoma group than that in the low-grade urothelial carcinoma group (P=1.40×10-5) or than that in the normal urothelium tissue group (P=2.11×10-4). We hypothesized that tumor hypoxia was responsible for differential expression of the AGGF1 protein in low- and high-grade urothelial carcinomas, and therefore investigated the molecular regulatory mechanism for AGGF1 expression under hypoxia. Under hypoxic conditions, AGGF1 protein levels declined without any change in mRNA levels and protein stability. Hypoxia-induced down-regulation of AGGF1 was mediated by miR-27a. Overexpression of miR-27a suppressed AGGF1 expression through translational inhibition, but not by RNA degradation. Moreover, the hypoxia-induced decrease of AGGF1 expression disappeared after miR-27a expression was inhibited. Furthermore, down-regulation of AGGF1 reduced hypoxia-induced apoptosis in cancer cells. Taken together, the results of this study indicate that (1) hypoxia down-regulates expression of the AGGF1 protein, but not AGGF1 mRNA, by inducing expression of miR-27a; (2) Down-regulation of AGGF1 had an apparent protective role for cancer cells under hypoxia; (3) Down-regulation of the AGGF1 protein confers a significant risk of high-grade human urothelial bladder carcinoma.
AB - Hypoxia stimulates angiogenesis under a variety of pathological conditions, including malignant tumors by inducing expression of angiogenic factors such as VEGFA. Surprisingly, here we report significant association between down-regulation of a new angiogenic factor AGGF1 and high-grade urothelial carcinoma. The proportion of strong AGGF1 expression cases was significantly lower in the high-grade urothelial carcinoma group than that in the low-grade urothelial carcinoma group (P=1.40×10-5) or than that in the normal urothelium tissue group (P=2.11×10-4). We hypothesized that tumor hypoxia was responsible for differential expression of the AGGF1 protein in low- and high-grade urothelial carcinomas, and therefore investigated the molecular regulatory mechanism for AGGF1 expression under hypoxia. Under hypoxic conditions, AGGF1 protein levels declined without any change in mRNA levels and protein stability. Hypoxia-induced down-regulation of AGGF1 was mediated by miR-27a. Overexpression of miR-27a suppressed AGGF1 expression through translational inhibition, but not by RNA degradation. Moreover, the hypoxia-induced decrease of AGGF1 expression disappeared after miR-27a expression was inhibited. Furthermore, down-regulation of AGGF1 reduced hypoxia-induced apoptosis in cancer cells. Taken together, the results of this study indicate that (1) hypoxia down-regulates expression of the AGGF1 protein, but not AGGF1 mRNA, by inducing expression of miR-27a; (2) Down-regulation of AGGF1 had an apparent protective role for cancer cells under hypoxia; (3) Down-regulation of the AGGF1 protein confers a significant risk of high-grade human urothelial bladder carcinoma.
KW - AGGF1
KW - Bladder urothelial carcinoma
KW - Hypoxia
KW - MiR-27a
UR - http://www.scopus.com/inward/record.url?scp=84894528778&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84894528778&partnerID=8YFLogxK
U2 - 10.1016/j.bbadis.2014.01.007
DO - 10.1016/j.bbadis.2014.01.007
M3 - Article
C2 - 24462738
AN - SCOPUS:84894528778
SN - 0925-4439
VL - 1842
SP - 712
EP - 725
JO - Biochimica et Biophysica Acta - Molecular Basis of Disease
JF - Biochimica et Biophysica Acta - Molecular Basis of Disease
IS - 5
ER -